| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.096 | 0.0005 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.1 | 0.0005 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.18 | 0.0006 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0007 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.095 | 0.0008 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.001 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.1 | 0.001 |